| Unlock ST Premium FREE Trial: Discover top stock picks & smart tools | |
| Good morning! U.S. stock futures were mixed early Thursday as investors assessed corporate earnings and awaited fresh economic data following a sell-off triggered by hotter-than-expected inflation. S&P 500 futures fell 0.30%, while Nasdaq-100 futures declined 1.09%; Dow futures gained 0.31%, or 167 points. In Wednesday’s session, the Nasdaq Composite dropped 1.9%, its steepest decline since July 23, while the S&P 500 slid 1.1%, its biggest one-day loss since July 29. The Dow fell just 0.1%. Concerns over tighter Federal Reserve policy intensified amid a global AI stock sell-off, with producer prices, retail sales and jobless claims due Thursday. | |
|
Top 5 Digital Assets Set to Surge Through 2025–2026
Inside, you’ll discover:
- ✅ How institutional capital is reshaping the crypto landscape
- ✅ Five digital assets positioned to benefit from the next growth wave
- ✅ Smart strategies for early positioning before mainstream momentum builds
👉 Access Your Free Report Here
By following the links above, you’re opting in to receive valuable updates from Wealthiest Investor News plus 2 bonus subscriptions. Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.
Sponsored
| |
|
Netcapital Inc (NCPL) stock soared 19.50% to $1.90 in the pre-market trading after regaining compliance with Nasdaq's minimum bid price requirement.
Idaho Copper Corp (AMEX: COPR) shares are trading up 10.19% at $2.92 at the time of writing after announcing results of an updated preliminary economic assessment for the CuMo Project: after-tax NPV of US$1.88 billion, 18.5% IRR, and a 46-Year Mine Life.
FBS Global Ltd (FBGL) grew over 11.25% at $2.67 in pre-market trading today after regaining compliance with Nasdaq minimum bid price requirement.
Niki BioSolutions Inc (NIKI) jumped about 4.89% at $2.25 in pre-market trading Thursday after announcing that its subsidiary, DiamiR Biosciences Corp., will test plasma samples for APOE genotypes in the GAP Bio-Hermes-002 study.
| |
| Top Upgrades & Downgrades | |
|
Jefferies turned bullish on Brinker International Inc (EAT), upgrading the stock to Buy and assigning a $255 price target, representing potential upside of 24.85% from Wednesday's close.
GXO Logistics Inc (GXO) has won the favor of Goldman's equity research team. The firm upgraded the shares from Neutral to Buy and moved its price target to $61, suggesting 32.98% additional upside for the stock.
Kontoor Brands Inc (KTB) received an upgrade from analysts at Jefferies, who also set their one-year price target on the stock to $89. They changed their rating on KTB to Buy from Hold in a recently issued research note.
BofA Securities reduced its rating on Albertsons Companies Inc (ACI) stock to Underperform from Neutral and assigned the price target to $12.
JP Morgan analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Bruker Corp (BRKR) has been changed to Neutral from Overweight and the new price target is set at $60.
Analysts at Goldman downgraded Carrier Global Corp (CARR) stock to Neutral from Buy, and the new price target is set at $61.
| |
|
"You can’t develop without this tool."
That’s what one AI veteran told us about a certain company we cover in our 10 Best AI
Stocks to Own in 2026 report.
Stock forecasters predict a 30%+ move higher by the end of 2026.
Click the link below and get this company’s name (plus 9 other AI leaders) for free today, before the list goes behind a paywall.
Send My Free Report
Sponsored
| |
|
Zone Frontier Inc (ZONE) Chief Executive Officer, Hassen Tyler Lewis, declared the purchase of shares taking place on Oct 14 '26 at $0.11 for some 750000 shares. The transaction amount was around $85,200.
Inhibrx Biosciences Inc (INBX) Chief Executive Officer, Lappe Mark bought on Oct 14 '26 a total of 10040 shares at $84.56 on average. The purchase cost the insider an estimated $848,977.
Cue Biopharma Inc (CUE) Chief Legal Compliance Officer, Ray Sumita, announced the sale of shares taking place on Oct 12 '26 at $28.05 for some 1844 shares. The total came to more than $51,724.
Paysign Inc (PAYS) CEO, Newcomer Mark sold on Oct 09 '26 a total 50000 shares at $15.34 on average. The insider’s sale generated proceeds of almost $766,895.
| |
|
 Josh has been with us since before Prosper Trading even existed — fifteen-plus years.
So when he put my 0-day options strategy to the test, he didn't take our word for it. He ran his own capital through it and tracked every pick, every entry, every exit for three straight weeks.
The result? Up more than 5,800 on three weeks of deployed capital — a 139 percent return on the money he put at risk. AMD ran better than ten times his risk. MSFT, more than thirteen.
It's a handful of trades on Thursday at 3PM each week — the kind that can expire the very next day, with the strike, entry, and exit spelled out for you. Not every trade wins, and we never hide the ones that don't.
Let me share with you exactly how it works in 1 simple report.
Charlie Moon
Thursday Blitz 0DTE service with Prosper Trading
Get the free 0-day options report
Sponsored
| |
|
Top US earnings releases scheduled for today include Telefonaktiebolaget LM Ericsson - ADR (ERIC). It will announce its September 2026 financial results. The company is expected to report earnings of $0.14 per share from revenues of $55.33B in the three-month period.
Analysts expect Taiwan Semicndctr Mnufctrng Co Ltd (TSM) to report a net income (adjusted) of $4.52 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended September 2026 is predicted to come in at $1.46.
US Bancorp (USB), due to announce earnings after the market closes today, is expected to report earnings of $1.32 per share on revenues of $8.01B for the recently concluded three-month period.
| |
| That's it for today. Thanks for reading. Good luck out there! Best Regards, Stocks Telegraph Team | |
| Disclaimer: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. | |
|
